These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 17625368)
1. Mutations of telomerase complex genes linked to bone marrow failures. Yamaguchi H J Nippon Med Sch; 2007 Jun; 74(3):202-9. PubMed ID: 17625368 [TBL] [Abstract][Full Text] [Related]
2. TERT and TERC mutations detected in cryptic dyskeratosis congenita suppress telomerase activity. Terada K; Miyake K; Yamaguchi H; Miyake N; Yamanaka K; Kojima S; Ito E; Inokuchi K; Okada T Int J Lab Hematol; 2020 Jun; 42(3):316-321. PubMed ID: 32150348 [TBL] [Abstract][Full Text] [Related]
3. Comparable Effects of the Androgen Derivatives Danazol, Oxymetholone and Nandrolone on Telomerase Activity in Human Primary Hematopoietic Cells from Patients with Dyskeratosis Congenita. Vieri M; Kirschner M; Tometten M; Abels A; Rolles B; Isfort S; Panse J; Brümmendorf TH; Beier F Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003434 [TBL] [Abstract][Full Text] [Related]
4. Dyskeratosis congenita and telomerase. Bessler M; Wilson DB; Mason PJ Curr Opin Pediatr; 2004 Feb; 16(1):23-8. PubMed ID: 14758110 [TBL] [Abstract][Full Text] [Related]
5. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex. Vulliamy TJ; Dokal I Biochimie; 2008 Jan; 90(1):122-30. PubMed ID: 17825470 [TBL] [Abstract][Full Text] [Related]
6. Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Yamaguchi H; Baerlocher GM; Lansdorp PM; Chanock SJ; Nunez O; Sloand E; Young NS Blood; 2003 Aug; 102(3):916-8. PubMed ID: 12676774 [TBL] [Abstract][Full Text] [Related]
7. An atypical form of dyskeratosis congenita with renal agenesis and no mutation in DKC1, TERC and TERT genes. Balci S; Engiz O; Erekul A; Gozdasoglu S; Vulliamy T J Eur Acad Dermatol Venereol; 2009 May; 23(5):607-8. PubMed ID: 19415813 [No Abstract] [Full Text] [Related]
8. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Batista LF; Pech MF; Zhong FL; Nguyen HN; Xie KT; Zaug AJ; Crary SM; Choi J; Sebastiano V; Cherry A; Giri N; Wernig M; Alter BP; Cech TR; Savage SA; Reijo Pera RA; Artandi SE Nature; 2011 May; 474(7351):399-402. PubMed ID: 21602826 [TBL] [Abstract][Full Text] [Related]
9. A telomerase component is defective in the human disease dyskeratosis congenita. Mitchell JR; Wood E; Collins K Nature; 1999 Dec; 402(6761):551-5. PubMed ID: 10591218 [TBL] [Abstract][Full Text] [Related]
10. Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation. de la Fuente J; Dokal I Pediatr Transplant; 2007 Sep; 11(6):584-94. PubMed ID: 17663679 [TBL] [Abstract][Full Text] [Related]
11. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer. Marrone A; Dokal I Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268 [TBL] [Abstract][Full Text] [Related]
12. Dyskeratosis congenita: a genetic disorder of many faces. Kirwan M; Dokal I Clin Genet; 2008 Feb; 73(2):103-12. PubMed ID: 18005359 [TBL] [Abstract][Full Text] [Related]
13. Dyskeratosis congenita: its link to telomerase and aplastic anaemia. Dokal I; Vulliamy T Blood Rev; 2003 Dec; 17(4):217-25. PubMed ID: 14556776 [TBL] [Abstract][Full Text] [Related]
14. Clinical and genetic features of dyskeratosis congenita, cryptic dyskeratosis congenita, and Hoyeraal-Hreidarsson syndrome in Japan. Yamaguchi H; Sakaguchi H; Yoshida K; Yabe M; Yabe H; Okuno Y; Muramatsu H; Takahashi Y; Yui S; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Inokuchi K; Ito E; Ogawa S; Kojima S Int J Hematol; 2015 Nov; 102(5):544-52. PubMed ID: 26329388 [TBL] [Abstract][Full Text] [Related]
15. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Vulliamy TJ; Walne A; Baskaradas A; Mason PJ; Marrone A; Dokal I Blood Cells Mol Dis; 2005; 34(3):257-63. PubMed ID: 15885610 [TBL] [Abstract][Full Text] [Related]
16. Advances in the understanding of dyskeratosis congenita. Walne AJ; Dokal I Br J Haematol; 2009 Apr; 145(2):164-72. PubMed ID: 19208095 [TBL] [Abstract][Full Text] [Related]
17. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Fogarty PF; Yamaguchi H; Wiestner A; Baerlocher GM; Sloand E; Zeng WS; Read EJ; Lansdorp PM; Young NS Lancet; 2003 Nov; 362(9396):1628-30. PubMed ID: 14630445 [TBL] [Abstract][Full Text] [Related]
18. Chemical inhibition of PAPD5/7 rescues telomerase function and hematopoiesis in dyskeratosis congenita. Shukla S; Jeong HC; Sturgeon CM; Parker R; Batista LFZ Blood Adv; 2020 Jun; 4(12):2717-2722. PubMed ID: 32559291 [TBL] [Abstract][Full Text] [Related]
19. High resolution melting analysis for the identification of novel mutations in DKC1 and TERT genes in patients with dyskeratosis congenita. Carrillo J; Martínez P; Solera J; Moratilla C; González A; Manguán-García C; Aymerich M; Canal L; Del Campo M; Dapena JL; Escoda L; García-Sagredo JM; Martín-Sala S; Rives S; Sevilla J; Sastre L; Perona R Blood Cells Mol Dis; 2012 Oct 15-Dec 15; 49(3-4):140-6. PubMed ID: 22664374 [TBL] [Abstract][Full Text] [Related]
20. Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita. Ly H; Schertzer M; Jastaniah W; Davis J; Yong SL; Ouyang Q; Blackburn EH; Parslow TG; Lansdorp PM Blood; 2005 Aug; 106(4):1246-52. PubMed ID: 15886322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]